Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Current Treatment Options in Oncology
|
July 9, 2025
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies
Imperia Nuzzolese, Stefano Cavalieri, Lisa F Licitra, et al.
BMC Cancer
|
June 30, 2014
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, et al.
Oral Oncology
|
March 3, 2017
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Salvatore Alfieri, Roberta Granata, Cristiana Bergamini, et al.
Targeted Oncology
|
January 14, 2025
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study
Antoine Desilets, Justin Lucas, Lisa F Licitra, et al.
Frontiers in Oncology
|
December 12, 2022
Salivary gland cancers in elderly patients: challenges and therapeutic strategies
Elena Colombo, Charlotte Van Lierde, Alexandra Zlate, et al.
Future Oncology (London, England)
|
February 17, 2022
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design
Jean Bourhis, Barbara Burtness, Lisa F Licitra, et al.
Frontiers in Oncology
|
March 17, 2023
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
Elena Colombo, Cristina Gurizzan, Arianna Ottini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2019
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
Ricard Mesia, Paolo Bossi, Aaron R Hansen, et al.
Archives of Pathology & Laboratory Medicine
|
December 1, 2018
Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting
Alessandro Franchi, Justin A Bishop, Hedley Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2023
Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111-24111)
Simon P Beyaert, Axelle E Loriot, Nicolas D Huyghe, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Current Treatment Options in Oncology
|
July 9, 2025
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies
Imperia Nuzzolese, Stefano Cavalieri, Lisa F Licitra, et al.
BMC Cancer
|
June 30, 2014
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, et al.
Oral Oncology
|
March 3, 2017
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Salvatore Alfieri, Roberta Granata, Cristiana Bergamini, et al.
Targeted Oncology
|
January 14, 2025
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study
Antoine Desilets, Justin Lucas, Lisa F Licitra, et al.
Frontiers in Oncology
|
December 12, 2022
Salivary gland cancers in elderly patients: challenges and therapeutic strategies
Elena Colombo, Charlotte Van Lierde, Alexandra Zlate, et al.
Future Oncology (London, England)
|
February 17, 2022
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design
Jean Bourhis, Barbara Burtness, Lisa F Licitra, et al.
Frontiers in Oncology
|
March 17, 2023
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
Elena Colombo, Cristina Gurizzan, Arianna Ottini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2019
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
Ricard Mesia, Paolo Bossi, Aaron R Hansen, et al.
Archives of Pathology & Laboratory Medicine
|
December 1, 2018
Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting
Alessandro Franchi, Justin A Bishop, Hedley Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2023
Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111-24111)
Simon P Beyaert, Axelle E Loriot, Nicolas D Huyghe, et al.
Page
of 3